Search Results 301-310 of 15221 for HCG

  1. Drugs and Supplements that Start with G - Mayo Clinic

    Explore a comprehensive list of prescription and over-the-counter medications starting with the letter “G” to learn about drug side effects, proper use and ...

  2. Publications - Juan P. Brito Campana, M.B.B.S. - Mayo Clinic

    Brito JP, Herrin J, Swarna KS, Singh Ospina NM, Montori VM, Toro-Tobon D, Umpierrez GE, Galindo RJ, Deng Y, Mickelson MM, Shao H, Polley EC, McCoy RG.

  3. Study Evaluating The Safety And Effectiveness Of JCARH125 In Subjects With Relapsed And/or Refractory Multiple Myeloma (EVOLVE) - Mayo Clinic

    Females of reproductive potential must have a negative serum beta human chorionic gonadotropin (ß-hCG) pregnancy test result at Screening and within 48 ...

  4. Riluzole In Spinal Cord Injury Study - Mayo Clinic

    Women of childbearing potential must have a negative serum β-human chorionic gonadotropin (β-hCG) pregnancy test or a negative urine pregnancy test; adults ...

  5. A Study to Assess Maternal and Fetal Outcomes in Pregnancy with Type 1 Diabetes Mellitus and Controls - Mayo Clinic

    The purpose of this study is to retrospectively and prospectively compare maternal and fetal/newborn clinical outcomes in age-matched pregnant patients with T1D ...

  6. Medical Research & Education - Mayo Clinic News Network

    Hormone therapy is the most effective treatment for managing menopause symptoms, particularly hot flashes, night sweats and sleep disturbances.

  7. An Extension Study Of Oral Ozanimod For Moderately-to-Severely Active Crohn's Disease - Mayo Clinic

    Subject is pregnant, lactating, or has a positive urine beta human chorionic gonadotropin (β-hCG). Subject has suspected or diagnosed intra-abdominal or ...

  8. Epilepsy and pregnancy: What you need to know - Mayo Clinic

    The medication you take during pregnancy can affect your baby. Birth defects — including cleft palate, neural tube defects, skeletal problems, and heart and ...

  9. A Phase 1 Study Evaluating Intratumoral Administration Of JNJ-1761981 ER In Solid Tumors - Mayo Clinic

    A participant of childbearing potential must have a negative highly sensitive serum (eg, β-hCG) pregnancy test at screening and within 72 hours of the first ...

  10. A Study Of CTX-009 In Combination With Paclitaxel In Adult Patients With Unresectable Advanced, Metastatic Or Recurrent Biliary Tract Cancers (COMPANION-002) - Mayo Clinic

    Female patients who are women of childbearing potential (WCBP) must have a negative pregnancy test (serum-human chorionic gonadotropin (hCG) or urine-hCG ...